Thus, reduced insulin levels and insulin activity may contribute to a number of pathological processes that characterize Alzheimer's disease (AD) such as synaptic loss, limited dendritic arborisation, and memory impairment [11]. This evidence concerns the gene INS and Alzheimer disease.